-
Something wrong with this record ?
Antiproliferative, DNA binding, and cleavage properties of dinuclear Co(III) complexes containing the bioactive quinizarin ligand
H. Crlikova, H. Kostrhunova, J. Pracharova, M. Kozsup, S. Nagy, P. Buglyó, V. Brabec, J. Kasparkova
Language English Country Germany
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Anthraquinones chemistry pharmacology MeSH
- DNA chemistry MeSH
- Cobalt chemistry pharmacology MeSH
- Coordination Complexes chemical synthesis chemistry pharmacology MeSH
- Humans MeSH
- Ligands MeSH
- Molecular Conformation MeSH
- Tumor Cells, Cultured MeSH
- Cell Proliferation drug effects MeSH
- Antineoplastic Agents chemical synthesis chemistry pharmacology MeSH
- Drug Screening Assays, Antitumor MeSH
- DNA Cleavage MeSH
- Binding Sites drug effects MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The adverse side effects and acquired resistance associated with the clinical application of traditional platinum-based anticancer drugs have forced investigation of alternative transition metal-based compounds and their cytostatic properties. Over the last years, the anticancer potential of cobalt complexes has been extensively studied, and in-depth analyses of their mode of action have been conducted. In this work, we present antiproliferative activity against human cancer cells of the dinuclear Co(III) complexes bearing the quinizarin ligand and tris(2-aminoethyl)amine (tren, compound 1) or tris(2-pyridylmethyl)amine (tpa, compound 2) co-ligands. To contribute the understanding mechanisms of biological action of these compounds, their association with DNA in the cells, DNA binding in cell-free media, and DNA cleavage capability were investigated in detail. The results demonstrate that both complexes interact with DNA in tumor cells. However, their mechanism of antiproliferative action is different, and this difference is mirrored by distinct antiproliferative activity. The antiproliferative effect of 1 is connected with its ability to intercalate into DNA and subsequently to inhibit activities of DNA processing enzymes. In contrast, the total antiproliferative efficiency of 2, thanks to its redox properties, appears to be connected with its ability to form radicals and, consequently, with the ability of 2 to cleave DNA. Hence, the findings presented in this study may significantly contribute to understanding the antitumor potential of cobalt complexes. Dinuclear Co(III) complexes containing the bioactive quinizarin ligand exhibit antiproliferative activity based on distinct mechanism.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21020717
- 003
- CZ-PrNML
- 005
- 20210830102334.0
- 007
- ta
- 008
- 210728s2020 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00775-020-01765-4 $2 doi
- 035 __
- $a (PubMed)32112290
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Crlikova, Hana $u Department of Biophysics, Faculty of Science, Palacky University, Slechtitelu 27, 78371, Olomouc, Czech Republic
- 245 10
- $a Antiproliferative, DNA binding, and cleavage properties of dinuclear Co(III) complexes containing the bioactive quinizarin ligand / $c H. Crlikova, H. Kostrhunova, J. Pracharova, M. Kozsup, S. Nagy, P. Buglyó, V. Brabec, J. Kasparkova
- 520 9_
- $a The adverse side effects and acquired resistance associated with the clinical application of traditional platinum-based anticancer drugs have forced investigation of alternative transition metal-based compounds and their cytostatic properties. Over the last years, the anticancer potential of cobalt complexes has been extensively studied, and in-depth analyses of their mode of action have been conducted. In this work, we present antiproliferative activity against human cancer cells of the dinuclear Co(III) complexes bearing the quinizarin ligand and tris(2-aminoethyl)amine (tren, compound 1) or tris(2-pyridylmethyl)amine (tpa, compound 2) co-ligands. To contribute the understanding mechanisms of biological action of these compounds, their association with DNA in the cells, DNA binding in cell-free media, and DNA cleavage capability were investigated in detail. The results demonstrate that both complexes interact with DNA in tumor cells. However, their mechanism of antiproliferative action is different, and this difference is mirrored by distinct antiproliferative activity. The antiproliferative effect of 1 is connected with its ability to intercalate into DNA and subsequently to inhibit activities of DNA processing enzymes. In contrast, the total antiproliferative efficiency of 2, thanks to its redox properties, appears to be connected with its ability to form radicals and, consequently, with the ability of 2 to cleave DNA. Hence, the findings presented in this study may significantly contribute to understanding the antitumor potential of cobalt complexes. Dinuclear Co(III) complexes containing the bioactive quinizarin ligand exhibit antiproliferative activity based on distinct mechanism.
- 650 _2
- $a anthrachinony $x chemie $x farmakologie $7 D000880
- 650 _2
- $a protinádorové látky $x chemická syntéza $x chemie $x farmakologie $7 D000970
- 650 _2
- $a vazebná místa $x účinky léků $7 D001665
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a kobalt $x chemie $x farmakologie $7 D003035
- 650 _2
- $a komplexní sloučeniny $x chemická syntéza $x chemie $x farmakologie $7 D056831
- 650 _2
- $a DNA $x chemie $7 D004247
- 650 _2
- $a štěpení DNA $7 D053837
- 650 _2
- $a screeningové testy protinádorových léčiv $7 D004354
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a molekulární konformace $7 D008968
- 650 _2
- $a nádorové buňky kultivované $7 D014407
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kostrhunova, Hana $u Czech Academy of Sciences, Institute of Biphysics, Kralovopolska 135, 61265, Brno, Czech Republic
- 700 1_
- $a Pracharova, Jitka $u Department of Biophysics, Centre of the Region Hana for Biotechnological and Agricultural Research, Palacky University, Slechtitelu 27, 78371, Olomouc, Czech Republic
- 700 1_
- $a Kozsup, Máté $u Department of Inorganic and Analytical Chemistry, University of Debrecen, Egyetem tér 1, Debrecen, 4032, Hungary
- 700 1_
- $a Nagy, Sándor $u Department of Inorganic and Analytical Chemistry, University of Debrecen, Egyetem tér 1, Debrecen, 4032, Hungary
- 700 1_
- $a Buglyó, Péter $u Department of Inorganic and Analytical Chemistry, University of Debrecen, Egyetem tér 1, Debrecen, 4032, Hungary
- 700 1_
- $a Brabec, Viktor $u Department of Biophysics, Faculty of Science, Palacky University, Slechtitelu 27, 78371, Olomouc, Czech Republic $u Czech Academy of Sciences, Institute of Biphysics, Kralovopolska 135, 61265, Brno, Czech Republic
- 700 1_
- $a Kasparkova, Jana $u Department of Biophysics, Faculty of Science, Palacky University, Slechtitelu 27, 78371, Olomouc, Czech Republic. jana@ibp.cz $u Czech Academy of Sciences, Institute of Biphysics, Kralovopolska 135, 61265, Brno, Czech Republic. jana@ibp.cz
- 773 0_
- $w MED00005752 $t Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry $x 1432-1327 $g Roč. 25, č. 2 (2020), s. 339-350
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32112290 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830102334 $b ABA008
- 999 __
- $a ok $b bmc $g 1691322 $s 1141163
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 25 $c 2 $d 339-350 $e 20200228 $i 1432-1327 $m JBIC, Journal of biological inorganic chemistry $n J Biol Inorg Chem $x MED00005752
- LZP __
- $a Pubmed-20210728
